1 / 28

RESCUE: Assessing Health and Economic Outcomes

RESCUE: Assessing Health and Economic Outcomes. William C. Black, M.D. Dartmouth-Hitchcock Medical Center. Outline. Health outcomes Economic outcomes CEA. Health Outcomes. MACE / Revacularization Life years (Vital Status) QALYs (SF-36) @ BL, 12 mos Angina Status. Life Years.

whitney-osborn
Download Presentation

RESCUE: Assessing Health and Economic Outcomes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESCUE: Assessing Health and Economic Outcomes William C. Black, M.D. Dartmouth-Hitchcock Medical Center

  2. Outline • Health outcomes • Economic outcomes • CEA

  3. Health Outcomes • MACE/ Revacularization • Life years (Vital Status) • QALYs (SF-36) @ BL, 12 mos • Angina Status

  4. Life Years • All observed deaths thru trial • All projected deaths after trial Framingham survival estimates based on age, sex, and CV events

  5. Quality Adjusted Life Year • Measure of patient utility • Measured on a scale of 0-1.0 • Can be assessed directly or derived, SG vs SF-36

  6. Standard Gamble

  7. 1.0 Quality Adjusted Life Years QALY = 0.5+0.25 = 0.75 Quality of Life 0.5 0 0.5 1.0 Quantity of Life

  8. QALYs

  9. QALYs • Derived from SF-36 @ BL, 1 yr • SS-6D utility scoring • Adjusted for age after trial

  10. SF-6D • Physical functioning • Role limitations • Social functioning • Pain • Mental health • Vitality

  11. SF-6D Utility Scoring U = 1.000 + ∑Score – 0.070 Brazier et al. J Health Econ 2002;21:271-92.

  12. QoL - Angina • CCS @ BL, 6, 12, 18, & 24 mos • SAQ @ BL, 12 mos • Not “preference” based

  13. Economic Outcomes • Direct cardiac* • inpatient care • outpatient care • medications • Indirect cardiac* • time and travel

  14. Economic Outcomes • Based on 201x dollars • Adjusted for timing w MC CPI • Projected by age beyond trial

  15. Hospitalization Costs • Triggered by patient questionnaire • DRGs and CPTs coded by MRA • Medicare reimbursement • Part A MEDPAR • Part B Physician Fee Schedule

  16. Outpatient Costs • Triggered by patient questionnaire • CPTs coded by MRA • Medicare Physician Fee Schedule • Red Book avg wholesale prices

  17. Indirect Costs • Triggered by patient questionnaire • Travel and other expenses • Timefrom usual activities

  18. CEA • Societal perspective • In-trial and lifetime horizons • Discounting @ 3% • Sensitivity analysis

  19. Base Case

  20. c II I ? Not Cost-Effective e III ? IV Cost-Effective Black. Med Decis Making 1990. 10(3): 212-4.

  21. c K II IB IA e IIIA IIIB IV Black. Med Decis Making 1990. 10(3): 212-4.

  22. Uncertainty • Sensitivity analysis • Scatterplot of ICE • CE Acceptability curves

  23. Sensitivity Analysis • LE • QALE • Costs • In-trial • Beyond-trial

  24. Weintraub, W. S. et al. Circ CardiovascQual Outcomes 2008;1:12-20

  25. Bootstrap Method • Sample n CTA subjects, compute C*CT, E*CT • Sample m SPE subjects, compute C*SP, E*SP • Plot ICE: (C*CT – C*SP, E*CT - E*SP) • Repeat steps 1-3 N times * mean

  26. Fenwick et al. BMC Health Serv Res 2006;6:52.

More Related